UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS. Guest User 08/11/2026 Guest User 08/11/2026 Neural Oscillatory and Sympathetic Arousal Dynamics During Mindfulness Meditation: Characterizing Relaxed Alertness Read More Guest User 08/11/2026 Guest User 08/11/2026 Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis Read More Guest User 08/11/2026 Guest User 08/11/2026 Digital meditation at scale: a randomized citizen science trial comparing four meditation practices Read More Guest User 08/11/2026 Guest User 08/11/2026 Ketamine, an interoceptive associative agent? Evidence from ketamine-assisted Mindfulness-Oriented Recovery Enhancement for opioid use disorder Read More Guest User 01/11/2026 Guest User 01/11/2026 After the Trip: A Qualitative Study of Healthy Individuals' Motor Experiences Following Different Doses of Psilocybin Read More Guest User 01/11/2026 Guest User 01/11/2026 Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study Read More Guest User 01/11/2026 Guest User 01/11/2026 Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients Read More Guest User 01/11/2026 Guest User 01/11/2026 Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts Read More Guest User 24/10/2026 Guest User 24/10/2026 Beyond psychedelic exceptionalism: how people combine meditation with psychoactive substances, and how this relates to well-being Read More Guest User 24/10/2026 Guest User 24/10/2026 An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder Read More Guest User 24/10/2026 Guest User 24/10/2026 Acute anxiogenic effects of psilocybin and the related tryptamine, norbaeocystin, in male and female rats Read More Guest User 24/10/2026 Guest User 24/10/2026 Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics Read More Guest User 17/10/2026 Guest User 17/10/2026 Adverse reactions to psychedelics in naturalistic settings are associated with current psychopathology and well-being: A correlational study Read More Guest User 17/10/2026 Guest User 17/10/2026 Music for psilocybin therapy and the temporal arc of psychedelic experience Read More Guest User 17/10/2026 Guest User 17/10/2026 Beyond the substance: A systematic review of psychological treatment frameworks in psychedelic-assisted therapy Read More Guest User 17/10/2026 Guest User 17/10/2026 Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability Read More Guest User 10/10/2026 Guest User 10/10/2026 Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms Read More Guest User 10/10/2026 Guest User 10/10/2026 Moving beyond 5-HT2A: language models map neurotransmitter receptors to experiential semantics Read More Guest User 10/10/2026 Guest User 10/10/2026 Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey Read More Guest User 10/10/2026 Guest User 10/10/2026 Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal–hippocampal circuitry Read More Older Posts
Guest User 08/11/2026 Guest User 08/11/2026 Neural Oscillatory and Sympathetic Arousal Dynamics During Mindfulness Meditation: Characterizing Relaxed Alertness Read More
Guest User 08/11/2026 Guest User 08/11/2026 Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis Read More
Guest User 08/11/2026 Guest User 08/11/2026 Digital meditation at scale: a randomized citizen science trial comparing four meditation practices Read More
Guest User 08/11/2026 Guest User 08/11/2026 Ketamine, an interoceptive associative agent? Evidence from ketamine-assisted Mindfulness-Oriented Recovery Enhancement for opioid use disorder Read More
Guest User 01/11/2026 Guest User 01/11/2026 After the Trip: A Qualitative Study of Healthy Individuals' Motor Experiences Following Different Doses of Psilocybin Read More
Guest User 01/11/2026 Guest User 01/11/2026 Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study Read More
Guest User 01/11/2026 Guest User 01/11/2026 Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients Read More
Guest User 01/11/2026 Guest User 01/11/2026 Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts Read More
Guest User 24/10/2026 Guest User 24/10/2026 Beyond psychedelic exceptionalism: how people combine meditation with psychoactive substances, and how this relates to well-being Read More
Guest User 24/10/2026 Guest User 24/10/2026 An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder Read More
Guest User 24/10/2026 Guest User 24/10/2026 Acute anxiogenic effects of psilocybin and the related tryptamine, norbaeocystin, in male and female rats Read More
Guest User 24/10/2026 Guest User 24/10/2026 Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics Read More
Guest User 17/10/2026 Guest User 17/10/2026 Adverse reactions to psychedelics in naturalistic settings are associated with current psychopathology and well-being: A correlational study Read More
Guest User 17/10/2026 Guest User 17/10/2026 Music for psilocybin therapy and the temporal arc of psychedelic experience Read More
Guest User 17/10/2026 Guest User 17/10/2026 Beyond the substance: A systematic review of psychological treatment frameworks in psychedelic-assisted therapy Read More
Guest User 17/10/2026 Guest User 17/10/2026 Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability Read More
Guest User 10/10/2026 Guest User 10/10/2026 Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms Read More
Guest User 10/10/2026 Guest User 10/10/2026 Moving beyond 5-HT2A: language models map neurotransmitter receptors to experiential semantics Read More
Guest User 10/10/2026 Guest User 10/10/2026 Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey Read More
Guest User 10/10/2026 Guest User 10/10/2026 Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal–hippocampal circuitry Read More